WORLDSymposium 2025
TOP 10 NOT-TO-BE-MISSED HIGHLIGHTS
- It is not too late to register for The Patient Voice 2025: Inequities in Access to Diagnosis, Care and Clinical Trials in Lysosomal Diseases session.
- Meet your next research collaborator, co-author, mentor, mentee, hiring manager, or new friend at the 3rd Annual Speed Mentoring Event.
- Congratulate the 2025 Catalyst Award recipient, Ryan Colburn, and participate in scheduled group photo opportunities.
- Celebrate James M. Wilson, MD, PhD as he receives the 2025 Roscoe O. Brady Award.
- Discuss the top basic science, translational and clinical abstracts of the year in 3 live poster sessions with over 400 posters presented.
- Honor Maria Kefalas and Dean and Teryn Suhr, the 2025 Patient Advocate Leader Award Recipients, and applaud the 2025 Young Investigator Award Recipients.
- Hear from the experts in The Situation Room: Gene Therapy in the Real World at the 4th Annual Robert J. Gorlin Symposium.
- Hear from Peter Marks, MD, PhD in his Keynote Address: Advancing the Frontier of Gene Therapy.
- Recognize important achievements in therapy for lysosomal diseases for treatments attaining regulatory approval with 3 outstanding new therapies at the 2025 New Treatment Awards.
- Discover the latest practice-changing research in 92 ground-breaking platform presentations on lysosomal diseases.
Now in its 21st year, WORLDSymposium is both the oldest and the largest annual international gathering of lysosomal disease experts from around the globe. For those looking forward to spending time with colleagues and peers in San Diego, WORLDSymposium is hosting live sessions, an exhibit hall, poster receptions and more not-to-be-missed events. See you in San Diego!
Be the Catalyst Event
Monday, February 3, 2025 from 18:00 to 19:30 PST
Back by popular request, “Be the Catalyst” is an exciting event, open to all WORLDSymposium participants. This event provides a great opportunity to reconnect with colleagues, make new connections, establish new relationships, welcome new attendees, and celebrate the achievements of past and present WORLDSymposium Award Recipients.
Be part of the scheduled group photos for all new attendees, past award recipients, genetic counselors and more!
Reception is open to all attendees. Come join the excitement!
Dates to Remember
New Date This Year: July 1, 2024
Distribution of exhibitor prospectus and support opportunities to all prior supporting companies, and also available by request.
July 15, 2024
Nominations for 2025 Patient Advocate Leader Award, the Roscoe O. Brady Award, the Catalyst Award and the New Treatment Award (corporations achieving regulatory approval milestones) open.
New Date This Year: August 1, 2024
Call for abstracts: Abstract submission website open. Registration for the conference and hotel block opens.
October 1, 2024 (17:00 CDT)
Deadline for abstract submission to WORLDSymposium 2025.
October 15, 2024
Deadline for submission of full-length manuscripts for peer-review in the “Lysosomes” issue of Molecular Genetics & Metabolism, February, 2025. Click here to access the Guide for Authors or to submit a paper. If you have any questions regarding the process for submitting a manuscript for the lysosomes issue, please contact the journal at mgm@elsevier.com.
November 1 – December 2, 2024
Late-breaking abstract submission open.
Due to the shorter schedule this year, a limited number of late-breaking abstracts will be selected for platform presentation.
November 4, 2024
Notification of abstract acceptance for poster or platform presentation at WORLDSymposium 2025.
November 15, 2024
Notification of WORLDSymposium 2025 Young Investigator Awards.
WORLDSymposium 2025 Full Program, Satellite Symposia and Industry Expert Theaters Posted
Preliminary Schedule at a Glance
Download Schedule at a Glance (PDF)
| Day | Monday Feb. 3, 2025 | Tuesday Feb. 4, 2025 | Wednesday Feb. 5, 2025 | Thursday Feb. 6, 2025 | Friday Feb. 7, 2025 |
|---|---|---|---|---|---|
| Satellite Symposia | Satellite Symposia | Satellite Symposia | Satellite Symposia | ||
| Morning | Roscoe. O. Brady Award Basic Science | Patient Advocate Leader & Young Investigator Awards Translational Research | Keynote Address Clinical Applications | New Treatment Award Contemporary Forum & Late-breaking Science | |
| Basic Science | Translational Research | Clinical Applications | Contemporary Forum & Late-breaking Science | ||
| Midday | Satellite Symposia | Satellite Symposia | Satellite Symposia | Satellite Symposia | |
| Afternoon | The Patient Voice | Basic Science | Translational Research | Clinical Applications | Rapid Fire Abstract Challenge |
| Speed Mentoring Event | Industry Expert Theater Poster Session I | Industry Expert Theater Poster Session II | Industry Expert Theater Poster Session III | ||
| Evening | Be the Catalyst Event | Satellite Symposia | Satellite Symposia | Robert J. Gorlin Symposium |
Plan on attending the
21st Annual WORLDSymposium
February 3, 2025: The Patient Voice
February 3 - 7, 2025: Research Meeting
February 6, 2025: Robert J. Gorlin Symposium
Manchester Grand Hyatt San Diego, San Diego, CA, USA
Scientific Meeting Location & Accommodations
Manchester Grand Hyatt San Diego
1 Market Place,
San Diego, CA 92101
Phone: +1 619 232 1234
Website: hyatt.com
Letters of Invitation
Your meeting registration confirmation will include a link to generate a customized letter of invitation, which can be used when applying for a visa.
About WORLDSymposium
WORLDSymposium™ is an annual research conference dedicated to lysosomal diseases.
WORLD is an acronym that stands for We’re Organizing Research on Lysosomal Diseases.
The goal of WORLDSymposium is to provide an interdisciplinary forum to explore and discuss specific areas of interest, research and clinical applicability related to lysosomal diseases. Each year, WORLDSymposium hosts a scientific meeting presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases.
This symposium is designed to help researchers and clinicians to better manage and understand diagnostic options for patients with lysosomal diseases, identify areas requiring additional basic and clinical research, public policy and regulatory attention, and identify the latest findings in the natural history of lysosomal diseases.
